This Article Free Full Text Free Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kang, Y. J. Search for Related Content PubMed PubMed Citation Articles by Kang, Y. J. Social Bookmarking                         What's this?

Cardiac Hypertrophy: A Risk Factor for QT-Prolongation and Cardiac Sudden Death

Departments of Medicine, Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky 40292, USA

Correspondence: Address correspondence to: Y. James Kang, Department of Medicine, 511 South Floyd St., MDR 530, University of Louisville School of Medicine, Louisville, Kentucky 40292, USA; e-mail:yjkang01{at}luoisville.edu

Cardiac hypertrophy was viewed as a compensatory response to hemodynamic stress. However, cumulative evidence obtained from studies using more advanced technologies in human patients and animal models suggests that cardiac hypertrophy is a maladaptive process of the heart in response to intrinsic and extrinsic stimuli. Although hypertrophy can normalize wall tension, it is a risk factor for QT-prolongation and cardiac sudden death. Studies using molecular biology techniques such as transgenic and knockout mice have revealed many important molecules that are involved in the development of heart hypertrophy and have demonstrated signaling pathways leading to the pathogenesis. With the same approach, the consequence of heart hypertrophy has been examined. The significance of hypertrophy in the development of overt heart failure has been demonstrated and several critical molecular pathways involved in the process were revealed. A comprehensive understanding of the threats of heart hypertrophy to patients has helped to develop novel treatment strategies. The recognition of hypertrophy as a major risk factor for QT-prolongation and cardiac sudden death is an important advance in cardiac medicine. Cellular and molecular mechanisms of this risk aspect are currently under extensively exploring. These studies would lead to more comprehensive approaches to prevention of potential life threatening arrhythmia and cardiac sudden death. The adaptation of new approaches such as functional genomics and proteomics will further advance our knowledge of heart hypertrophy.

Key Words: Arrhythmia • cardiac hypertrophy • cardiac sudden death • heart failure • maladaptive response • QT-prolongation • signaling pathway

Toxicologic Pathology, Vol. 34, No. 1, 58-66 (2006)
DOI: 10.1080/01926230500419421


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. Jin, E. R. Chemaly, A. Lee, C. Kho, L. Hadri, R. J. Hajjar, and F. G. Akar Mechanoelectrical remodeling and arrhythmias during progression of hypertrophy FASEB J, February 1, 2010; 24(2): 451 - 463. [Abstract] [Full Text] [PDF]

				J. Qu, F. M. Volpicelli, L. I. Garcia, N. Sandeep, J. Zhang, L. Marquez-Rosado, P. D. Lampe, and G. I. Fishman Gap Junction Remodeling and Spironolactone-Dependent Reverse Remodeling in the Hypertrophied Heart Circ. Res., February 13, 2009; 104(3): 365 - 371. [Abstract] [Full Text] [PDF]

				T. G. Diness, Y.-H. Yeh, X. Y. Qi, D. Chartier, Y. Tsuji, R. S. Hansen, S.-P. Olesen, M. Grunnet, and S. Nattel Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome Cardiovasc Res, July 1, 2008; 79(1): 61 - 69. [Abstract] [Full Text] [PDF]